Five Prime Therapeutics, Inc. (FPRX): Price and Financial Metrics


Five Prime Therapeutics, Inc. (FPRX)

Today's Latest Price: $4.31 USD

0.37 (-7.91%)

Updated Dec 13 12:00am

Add FPRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 325 in Biotech

See all "A" rated Strong Buy stocks

FPRX Stock Summary

  • Five Prime Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 10.51% of US listed stocks.
  • Revenue growth over the past 12 months for Five Prime Therapeutics Inc comes in at -70.01%, a number that bests merely 1.93% of the US stocks we're tracking.
  • In terms of volatility of its share price, FPRX is more volatile than 95.22% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Five Prime Therapeutics Inc are BCRX, CTMX, ATHX, INO, and CNAT.
  • Visit FPRX's SEC page to see the company's official filings. To visit the company's web site, go to www.fiveprime.com.
FPRX Daily Price Range
FPRX 52-Week Price Range

FPRX Stock Price Chart More Charts


FPRX Price/Volume Stats

Current price $4.31 52-week high $13.84
Prev. close $4.68 52-week low $3.18
Day low $4.28 Volume 400,000
Day high $4.67 Avg. volume 383,888
50-day MA $3.91 Dividend yield N/A
200-day MA $7.04 Market Cap 156.85M

Five Prime Therapeutics, Inc. (FPRX) Company Bio


Five Prime Therapeutics discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. The company was founded in 2001 and is based in South San Francisco, California.





FPRX Latest News Stream


Event/Time News Detail
Loading, please wait...

FPRX Latest Social Stream


Loading social stream, please wait...

View Full FPRX Social Stream

FPRX Price Returns

1-mo 22.79%
3-mo -23.85%
6-mo -34.00%
1-year -55.29%
3-year -91.54%
5-year -80.34%
YTD -53.66%
2018 -57.57%
2017 -56.26%
2016 20.75%
2015 53.70%
2014 60.81%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5166 seconds.